Tag: Gavi

COVID-19: Understanding anti-vaccine sentiment in South Africa

South Africa’s first clinical trial of a COVID-19 vaccine is entering its fourth week, with around 2000 volunteers participating. However, following the start of the trial, anti-vaccine protestors took to the streets to convey their concerns and sentiments with vaccine testing. Thabani Maphosa, Managing Director for Country Programmes at Gavi spoke to CNBC Africa for more.

Improving access to immunisation in Africa

Remarkable efforts have been made in making immunisation more accessible in the world. However, the fact that one out of five children misses out on vaccination proves that there’s a lot that needs to be done. Anuradha Gupta, Deputy CEO of GAVI, Vaccine Alliance joins CNBC Africa to discuss ways to improve vaccination especially in Africa where millions of infants are still not reached with routine immunization services.

Op-Ed: Protecting Africa’s invisible children, the case for birth registration and a digital identity

To achieve truly universal access will involve the strengthening and expansion of primary health care in low and middle income countries.

Op-Ed: Africa is now in serious danger of sleepwalking into a cancer crisis

Dr Ngozi Okonjo-Iweala discusses ways of saving future generations of African women from cervical cancer.